---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-26-000010"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2026-01-02T23:59:59+00:00"
generated_at: "2026-05-16T11:47:11.250500+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma changes fiscal year-end from March 31 to December 31, effective 2025

## Summary
- Board approved fiscal year change from March 31 to December 31, effective Dec 31, 2025.
- Company will file a Transition Report on Form 10-K for the nine-month period April 1 to Dec 31, 2025.
- Future fiscal years will end on December 31, aligning with the calendar year.

## SEC filing metadata
- accession: 0001185185-26-000010
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2026-01-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000010/0001185185-26-000010-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000010/igc8k010226.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-26-000010
- JSON: https://secwatch.observer/filing/0001185185-26-000010.json
- Plain text: https://secwatch.observer/filing/0001185185-26-000010.txt

## Source-grounded claims
- claim_id: aff8432607a99073361bcfebc78df70aea9fa910
  claim: IGC Pharma, Inc.: Changed fiscal year-end from March 31 to December 31 (effective 2025-12-31).
  evidence_excerpt: the Board of Directors (the “Board”) of IGC Pharma, Inc. (the “Company”) approved a change in the Company’s fiscal year-end from March 31 to December 31. The fiscal year change will be effective on December 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000010/0001185185-26-000010-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.